Effects of crystalline glucocorticoid triamcinolone acetonide on cultered human supraspinatus tendon cells by Tempfer, Herbert et al.
Acta Orthopaedica 2009; 80 (3): 357–362  357
Effects of crystalline glucocorticoid triamcinolone acetonide 
on cultered human supraspinatus tendon cells 
Herbert Tempfer1,2, Renate Gehwolf2,3, Christine Lehner3, Andrea Wagner1, Maia Mtsariashvili2, 
Hans-Christian Bauer1,2, Herbert Resch2,3, and Mark Tauber3
1Department of Organismic Biology, Division of Zoology and Functional Anatomy, University of Salzburg; 2Applied Cell Bioloogy and Developmental 
Biology Unit, Paracelsus Private Medical University, Salzburg; 3Department of Traumatology and Sports Injuries, University Hospital of Salzburg, Salzburg, 
Austria. HT and RG contributed equally to this paper.
Correspondence HT: Herbert.Tempfer@sbg.ac.at
Submitted 08-03-17. Accepted 08-09-12
Copyright © Informa Healthcare Ltd 2009. ISSN 1745–3674. Printed in Sweden – all rights reserved.
DOI 10.3109/17453670902988360
Background   Rotator cuff tears are a common cause of shoulder 
pain and impairment. Subacromial glucocorticoid injections are 
widely used for treatment of epiphenomenons of chronic impinge-
ment syndrome with the possible side effects of tendon rupture 
and impaired tendon healing. 
Methods   Using qRT-PCR, western blot, immunoflourescence, 
and  measurement  of  3H-thymidine  uptake  we  investigated  the 
effects of the crystalline glucocorticoid triamcinolone acetonide 
(TAA) when added to the culture medium of isolated human rota-
tor cuff tendon cells. 
Results   After 2 weeks of incubation, the cells had lost their 
fibroblastic appearance and parallel orientation, which is char-
acteristic of cellular degeneration in vivo. Moreover, expression 
and secretion of collagen I was strongly reduced, and there was 
a decrease in proliferation rate. Cell migration was blocked and 
the rate of expression of the matrix metalloproteinases MMP2, 
MMP8,  MMP9,  and  MMP13  was  reduced,  but  expression  of 
TIMP1 (a tissue inhibitor of MMPs) was upregulated, indicating 
a reduction in the cellular capacity for tendon repair. In addition, 
changes in cellular differentiation were observed: the number of 
adipocytes increased and levels of the protein Sox9—a marker of 
differentiating and mature chondrocytes—were elevated in tri-
amcinolone acetonide treated cells.
Interpretation   These results may indicate that the use of TAA 
is one reason for weaker mechanical tendon properties and for the 
high rate of re-rupture after supraspinatus tendon repair.

Rotator cuff tears causing shoulder pain and disability are 
common and may be caused by trauma or chronic degenera-
tive processes. Subacromial injection of long-acting cortico-
steroids is a common treatment to relieve shoulder pain and 
inflammation. The short-term effect is satisfactory (McInerey 
et al. 2006). However, some studies have suggested that there 
can be impairment of mechanical tendon properties and a high 
rate of tendon rupture after long-term treatment (Hugate et al. 
2004, Nichols 2005). When glucocorticoids are injected into 
an intact bursa, no direct contact between the corticoid crys-
tals and the tendon cells is to be expected. If the supraspinatus 
tendon is at least partially torn or the bursa is damaged, how-
ever, it is likely that there will be contact between the corti-
coid and cells—with possibly negative side effects. Moreover, 
injection experiments in cadavers have revealed an inaccu-
racy rate of up to 40% for intrabursal injection of substances 
directly into the tendon (Mathews and Glousman 2005).
 Several reports have described the effects of glucocorticoids 
on tendon cells and chondrocyte cultures. Scutt et al. (2006) 
showed that dexamethasone treatment inhibits cell prolifera-
tion and reduces collagen synthesis in primary rat tail tendon 
cells. In addition, an inhibitory effect of glucocorticoids on 
tendon  cell  proliferation  and  proteoglycan  production  has 
been found in vitro and in vivo (Wong et al. 2004).
Most studies on the effects of corticosteroids in in vitro sys-
tems have used the lipoid corticosteroid dexamethasone (Scutt 
et al. 2006). It has been shown that triamiconolone acetonide 
(TAA) reduces proteoglycane synthesis and that dexametha-
sone inhibits the migration of tendon cells (Tsai et al. 2003, 
Wong et al. 2005).
In this paper, we show for the first time the effects of TAA 
on cell proliferation, collagen synthesis and secretion, produc-
tion of matrix remodeling molecules, and differentiation status 
in primary cultures of human supraspinatus tendon cells.
Material and methods
Materials
DMEM, collagenase, and fetal calf serum were obtained from 
Gibco/Invitrogen (Lofer, Austria). Cell culture plastic mate-
rial was obtained from Nunc (Roskilde, Denmark). All other 
chemicals were purchased from Sigma (Vienna, Austria). For 358  Acta Orthopaedica 2009; 80 (3): 357–362
triamcinolone acetonide treatment, the brand product Volon 
A40 (Dermapharm GmbH, Vienna, Austria) was used.
The antibodies used for immunohistochemistry were anti-
Sox9 (rabbit polyclonal sc-20095; Santa Cruz Biotechnology, 
santa Cruz, CA) and anti-collagen I (rabbit polyclonal ab292; 
Abcam, Cambridge, UK). 
Isolation and culture of tendon-derived cells
Supraspinatus tendon cells (STCs) were isolated from biopsies 
of intact human supraspinatus tendons, which were obtained 
during posttraumatic surgical interventions not involving the 
rotator cuff (open Bankart repair in 3 patients, open glenoid 
fracture fixation in 4 patients) with informed consent from the 
patients (3 males aged 15, 35, and 40, and 4 females aged 39, 
43, 45, and 56).
The biopsies (weighing about 0.5 g each) were cut into small 
pieces under sterile conditions, followed by a 4-h digestion in 
DMEM supplemented with 30 mg/mL collagenase II (Gibco) 
at 37°C, 95% humidity, and 5% CO2. After digestion, the cells 
were pelleted, washed in PBS, and subsequently cultured in 
25-cm2 cell culture flasks with DMEM supplemented with 
10% fetal bovine serum (FBS). The method described yields 
50 cm2 of subconfluent STCs after 1 week of culture. Sub-
confluent cells were incubated with DMEM, 10% FBS, and 1 
mg/mL TAA for 2 weeks. For the proliferation assay, the cells 
were incubated for only 1 week. Control cells were incubated 
with DMEM and 10% FBS for the same periods of time.
The cultures obtained from each single patient were treated 
separately. All experiments described were performed either 
with primary cultures of tendon cells or with cells passaged 
once. 
Cell characterization
Adipocytes were stained with a 0.5% Sudan III solution for 
30 min at 37°C, and the proportion of positive cells was deter-
mined. Chondrocytes were identified by western blot using 
anti-Sox9 antibody. Sox9 has been reported to be a potent acti-
vator of type II collagen expression and is commonly used as 
a phenotypic marker of articular chondrocytes (Bi et al. 1999). 
In addition, accumulation of mucopolysaccharides associated 
with chondrocyte differentiation was shown by Alcian blue 
staining (Phornphutkul et al. 2006). 
For immunofluorescence, STCs grown on coverslips were 
fixed for 5 min in 100% methanol at –20°C. The cells were 
washed 3 times with phosphate-buffered saline and were per-
meabilized for 10 min in 0.25% Triton X-100 in phosphate-
buffered saline, followed by three washing steps. After block-
ing for 30 min in 5% BSA in phosphate-buffered saline at 
room temperature, the fixed cells were incubated overnight 
with  rabbit  anti-Sox9  antibody  (diluted  1:100  in  blocking 
solution) at 4°C. After 3 washes, the cells were incubated with 
secondary  antibody  (Alexa  Fluor  568  goat  anti-rabbit  IgG 
diluted 1:2,000 in blocking solution) for 1 h at 37°C. After 3 
final washing steps, the coverslips were mounted with Mowiol 
4-88 (Calbiochem). Images were taken using a Zeiss Axio-
plan microscope equipped with the Zeiss AxioVision imaging 
system. 
Determination of collagen I secretion western blot-
ting and proliferation assay
The measurement of collagen I secretion was done as described 
by Yang et al. (2004). Briefly, 1 mL of cell supernatant was 
digested with 100 µg/mL pepsin under acidic conditions, pre-
cipitated with 3M NaCl, dialyzed against 0.05 M NH4CO3, 
and vacuum dried. 
For western blot, proteins in the supernatant were separated 
by polyacrylamide gel electrophoresis (SDS-PAGE). For each 
sample, equal amounts of protein were loaded. The protein 
content of lyzed cells was measured with the BCA protein 
assay  kit  (Pierce).  Blotting  was  performed  as  previously 
described by Yang et al. (2004) using the rabbit polyclonal 
antibody directed against collagen I (ab292; Abcam).
Proliferation was measured with the 3H-thymidine incorpo-
ration assay. Cells were seeded in 24-well plates at a density 
of 5 × 105 cells per well and incubated with triamcinolone ace-
tonide (TAA). The controls were not treated with TAA. After 
24 h, 48 h, and 96 h of incubation with 1 µCi 3H-thymidine for 
6 h each, the cells were harvested, lysed in 1 M NaOH, and the 
radioactivity measured in a β-scintillation counter (Beckman). 
All reading points for each patient were done in triplicate. We 
used counts per minute per mg protein as a measure of cell 
proliferation, and background counts were subtracted.
RNA preparation and quantitative real-time (qRT-) PCR
Total RNA was isolated using the PureZol RNA isolation kit 
(BioRad). RNA yield and integrity were evaluated spectro-
photometrically and by agarose gel electrophoresis. Prior to 
first-strand cDNA synthesis, 1 µg total RNA was digested with 
DNase I (Fermentas, St. Leon-Roth, Germany). Reverse tran-
scription was performed according to Gehwolf et al. (2002). 
Primers for qRT-PCR were designed to be intron spanning 
according  to  the  annotated  human  sequences  of  MMP2, 
MMP9, TIMP1,  GAPDH,  and  HPRT,  respectively  (Table). 
The PCR was carried out in a Stratagene MX3000 real-time 
PCR cycler using the dsDNA-binding fluorescent dye SYBR-
green I (Invitrogen) in a reaction volume of 50 µL.
All samples were analysed in triplicate. A single reaction 
contained 1 µL cDNA, 1 unit TrueStart Taq DNA polymerase 
(Fermentas), 1 × Taq DNA polymerase reaction buffer (Fer-
mentas), 3.5 mM MgCl2, each dNTP at 0.2 mM, each of the 
primers at 300 nM, and 0.1 × SYBR-green I. The thermal 
cycling program consisted of an initial denaturation step of 3 
min at 95°C followed by 40 cycles of 30 seconds at 95°C, 30 
seconds at 58°C, and 30 seconds at 72°C. Melting curve anal-
ysis and agarose gel electrophoresis were performed to ensure 
that  a  single  PCR  product  had  been  amplified.  Reactions 
without template were included as negative controls. Tran-
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and HPRT mRNAs. Non-quantitative RT-PCR amplification 
of MMP1, MMP3, MMP8, MMP13, and MMP14 was per-
formed with the same PCR reaction conditions but without 
SYBR-green. PCR products were analyzed using agarose gel 
electrophoresis and visualized by ethidium bromide staining. 
Gelatin zymography
Gelatine zymography was performed as described previously 
(Krizbai, et al. 2000). Briefly, cells were lysed in a buffer con-
taining 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton 
X-100, and 0.1% SDS. Equal amounts of protein were loaded 
on 7.5% polyacrylamide gels containing casein (1 mg/mL). 
Following electrophoresis, the gels were given two 10-min 
washes with ddH2O containing 2.5% Triton X-100, then incu-
bated with a substrate buffer (50 mM Tris-HCl (pH 8.0) con-
taining 5 mM CaCl2). The gels were then stained with Coo-
massie blue for 15 min followed by several washing steps.
Wounding assay
After cells cultured on collagen-coated coverslips had reached 
confluence, the cell layers were wounded with a razor blade. 
The coverslips were then rinsed with PBS and cultured for 
another 24 h, either with TAA or without (controls). Any cells 
migrating from the wound edge into the denuded area were 
observed and documented.
Statistics
In all graphs, means and standard deviations are given. Stu-
dent’s t-test was used to test for effects of TAA treatment, and 
the significance level was set at p = 0.05.
Results
Already  after  1  week,  the  number  of  adipocytes  identified 
increased. After 2 weeks of incubation with TAA, a 20-fold 
increase in adipocytes was observed compared to untreated 
controls (Figure 1). The total number of adipocytes did not 
exceed 0.4% of all treated cells. 
The adipocytes usually appeared in groups of 3–4 cells—
in contrast to the spontaneously differentiated control cells, 
which only showed single adipocytes (Figure 1). Generally, 
these groups of cells were found to have direct physical con-
tact with crystalline clusters of TAA. 
Western blot analysis showed upregulation of Sox9 in TAA-
treated cells (Figure 2). Secretion of collagen type I was reduced. 
Staining with Alcian blue showed positive cells in the treatment 
group, whereas no stained cells were found in the controls. Of 
10,000 cells counted, 89 positive cells were found. 
Cell proliferation was significantly reduced as a result of 
treatment with TAA, by a factor of 3 compared to untreated 
cells within 96 hours (Figure 2).
Primer sequences for RT-PCR and quantitative RT-PCR
Gene    Forward primer sequence   Reverse primer sequence   Accession no.
product
MMP1   5´-TAGAACTGTGAAGCATATCGATG-3´   5´-AGTTGAACCAGCTATTAGCTTTC-3´   NM_002421
MMP2   5´-TCTACTCAGCCAGCACCCTGGA-3   5´-TGCAGGTCCACGACGGCATCCA-3´   NM_004530.2
MMP3   5´-TACTGGAGATTTGATGAGAAGAG-3´   5´-TACAGATTCACGCTCAAGTTCC-3´   NM_002422
MMP8   5´-TCAGGTGCCTTTCCAGGAATAG-3´   5´-TACAGTGATGGGAAACAATGAC-3´   NM_002424
MMP9   5´-TTCGACGTGAAGGCGCAGATGGT-3´   5´-TAGGTCACGTAGCCCACTTGGTC-3´   NM_004994.2
MMP13   5´-TGCAGCTGTTCACTTTGAGGA -3´   5´-TGGCATGACGCGAACAATACG-3´   NM_002427
MMP14   5´-TACCGACAAGATTGATGCTGCTC-3´   5´-TCTACCTTCAGCTTCTGGTTG-3´   NM_004995
TIMP1   5´-TGGACTCTTGCACATCACTACCTGC-3´   5´-AGGCAAGGTGACGGGACTGGAA-3´   NM_003254.2
GAPDH   5´-AACATCATCCCTGCCTCTAC-3´   5´-CTGCTTCACCACCTTCTTG-3´   NM_002046
HPRT   5´-TGCTTTCCTTGGTCAGGCAGTATA-3´   5´-GCGATGTCAATAGGACTCCAGAT-3´   NM_000194
Figure 1. A. Clusters of differentiated adipocytes with typical lipid droplets in cells (black arrow) after treatment with triamicolone 
acetonide. The green arrow indicates triamicolone acetonide crystals. B. Untreated cells show a spindle-shaped phenotype typi-
cal of tendon cells, whereas treated cells totally lose their orientation (right panel). * p < 0.001.
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 In qRT-PCR applications, expression of MMP2 and MMP9 
mRNA was found to be significantly downregulated by TAA 
treatment—by 58% (SD 0.9) for MMP2 and by 72% (SD 1.9) 
for MMP9—whereas the expression of TIMP1 mRNA was 
upregulated by 111% (SD 21). The decrease in MMP2 and 
MMP9 levels was confirmed by gelatine zymography. In the 
case of MMP9, all the functional forms of the enzyme that 
have been described to date (active MMP9 with a size of 92 
kD, pro-MMP9 of about 130 kD, and the homodimer of 225 
kD) were downregulated (Figure 3). 
RT-PCR revealed downregulation of MMP8 and MMP13 
mRNAs  after  TAA  treatment;  no  changes  in  the  levels  of 
MMP1, MMP3, and MMP14 mRNAs were found (Figure 3).
 The wounding assay showed total blockage of cell migra-
tion in TAA-treated cells, whereas the control cells actively 
migrated into the wounded area (Figure 4).
The TAA product used (with brand name Volon A40) con-
tains the preservative phenyl carbinol at a concentration of 
40 mg/mL. No effects were observed in cells incubated with 
phenyl carbinol at a concentration of 40 mg/mL.
Discussion
We focused our investigations on the supraspinatus tendon, the 
most frequently affected tendon in rotator cuff injuries. For this 
study, we only used tendons with no signs of degeneration. We 
hypothesized that any observed degeneration caused by TAA 
on healthy tendon would be likely to aggravate impairment on 
an initially damaged tendon. Moreover, contact between TAA 
and intact tendon material appears to occur surprisingly often, 
since up to 40% of all intrabursal injections are reported to 
Figure 2. A. Downregulation of collagen type I secretion in TAA-treated supraspinatus 
tendon cells (STCs) (a: treated cells; b: control). The two separate bands seen in blot 
A are α1 chain and α2 chain of collagen type I, respectively. B. Sox9 is upregulated 
in treated cells (d) relative to control cells (c). C. TAA-treated cells show a decrease in 
3H-thymidine uptake depending on the duration of TAA treatment. D. After TAA treat-
ment, several cells stained positively for Sox9, whereas no positive cells were found 
in the control (not shown). * p < 0.001.
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Figure 3. A. Results of gelatin zymography showing the downregulation of MMP2 and MMP9 by triamcinolone acetonide (right lane) compared to 
untreated control cells (left lane). RT-PCR result showing downregulation of MMP2, MMP8, MMP9, and MMP13 mRNA levels after TAA treatment. 
B. Levels of MMP1, MMP3, and MMP14 mRNA were unchanged. C. qRT-PCR showed significant downregulation of MMP2 and MMP9 mRNA 
levels, and significant upregulation of TIMP1 mRNA. Gene expression levels of MMP2, MMP9, and TIMP1 were normalized to the expression of 
housekeeping genes GAPDH and HPRT. * p < 0.001.
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come in contact with intact tendons, and thus with tendon cells 
(Mathews and Glousman 2005). 
We used an in vitro model of cultured tendon cells because 
it is the only choice to study the immediate effects of TAA on 
cells during a short period of time. In our experiments only 
one concentration of TAA was used, which is similar to that to 
which the tendon cells in tissue are exposed. Due to the poor 
solubility of TAA in culture media and buffer solutions, dose-
dependent effects are difficult to interpret. Also, due to the 
chemical nature of TAA, the substance is slowly dissolving in 
aqueous solution but it is slowly diffusing in tissue or cellular 
layers. While the use of organic solvents would increase solu-
bility in culture, they would not reflect the in vivo situation.
We found that TAA caused a decrease in proliferation rates 
and collagen synthesis, and also triggered a differentiation 
process resulting in an increased number of adipocytes and 
chondrocytes after 2 weeks in culture. Moreover, TAA inhib-
ited tendon cell migration by downregulating the expression 
of matrix metalloproteinases MMP2 and MMP9 with concur-
rent upregulation of TIMP1. 
Corticosteroids have a directly inhibitory effect on the tran-
scription of MMP9, which may be one reason for the effects 
observed (Van den Steen et al. 2002). Moreover, hydrocor-
tisone  has  been  shown  to  inhibit  transcription  of  both  the 
MMP2 and MMP9 genes, by influencing the binding activity 
of activating protein 1 (AP1) (Aljada et al. 2001).
We chose MMP2 and MMP9 for this study because of their 
essential role in tendon cell migration, which is likely to be 
important  for  tendon  healing.  Moreover,  they  are  also  key 
players in neovascularization of renewed tissue (Ragoowansi 
et al. 2003). Thus, it is feasible that any alteration in MMP2 
and MMP9 levels and their relative ratios to TIMP1 may affect 
the healing potential of injured or freshly reconstructed tendon 
tissue.
Generally, MMPs and TIMPs are reported to play a major 
role in tendon diseases and in tendon healing. Expression of 
MMP13, for example, has been shown to be elevated in torn 
rotator cuff tendons (Lo et al. 2004).
Downregulation  of  collagen  type  I  synthesis  in  tendon-
derived  cells  caused  by  dexamethasone  has  already  been 
described (Scutt et al. 2006). Our data show that it was not 
only the amount of collagen type I that was reduced by the 
glucocorticoid TAA: the level of secretion of collagen type 
I (which is known to be important for tendon stability) was 
affected (Kannus 2000). 
One reason for the reduced rate of collagen type I secre-
tion  could be the change in terminal differentiation of tendon 
cells caused by TAA, as suggested by our data. However, the 
number of newly formed adipocytes and chondrocytes after 
incubation of tendon cell cultures with TAA was too low to 
explain this decrease. The fact that glucocorticoids give rise to 
other cells in culture is interesting. In vivo, these differentia-
tion processes may act over a longer time period with so far 
unknown effects on tendon strength.
As a third cellular parameter, we chose cell proliferation as 
a response to corticoid treatment. The observed reduction in 
proliferation may possibly be associated with a reduced intra-
cellular level of TGF-b, which has been shown to be caused by 
triamcinolone (Carroll et al. 2002). Generally, mature tendon 
cells have very low proliferative capacity with a proliferation 
index around 1% (Matsuda 1994). However, under conditions 
of culture a small population of these cells seems to be induced 
to proliferate (Scutt et al. 2006). Conceivably, this population 
plays a major role in tendon healing, not least because of the 
stem cell properties attributed to some tendon-derived cells 
(Salingcarnboriboon et al. 2003, Bi et al. 2007). Thus, the 
deceleration of proliferation may contribute to the impaired 
tendon healing described by Nichols (2005) as a negative side 
effect  of  local  steroid  treatment  in  ruptured  supraspinatus 
tendon. Reduced matrix turnover and cell migration are further 
possible reasons for the weakening of the tendon’s mechanical 
properties, and could be jointly responsible for the high failure 
rate reported after rotator cuff repair (Jost et al. 2000, Mel-
lado et al. 2006). Watson (1985) reported a poorer outcome 
in a series of 89 cases after rotator cuff repair in patients with 
more than 4 preoperative local steroid injections. A correlation 
was seen between a higher number of steroid injections and a 
softer residual cuff, and it is assumed that poor results were 
due to this soft tissue (Matsuda 1994).
Based on our findings, for therapeutic purposes cautious 
application  of  crystalline  TAA  is  reasonable,  especially  in 
cases with already diagnosed rotator cuff tears and subsequent 
cuff  repair.  This  study  also  emphasizes  the  importance  of 
accurate intrabursal injection. Finally, future studies will show 
whether the effects of crystalline TAA observed here can also 
be seen in other tendon tissue.
Figure 4. Within 24 h, TAA had totally inhibited cell migration whereas 
untreated  control  cells  could  apparently  invade  the  denuded  area 
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